Highly efficient Cas9-mediated transcriptional programming
about
Recent Advances in Genome Editing Using CRISPR/Cas9Concise review: programming human pluripotent stem cells into bloodBeyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogationApplications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology ResearchEnabling functional genomics with genome engineeringStrategies for precision modulation of gene expression by epigenome editing: an overviewThe New State of the Art: Cas9 for Gene Activation and RepressionVersatile protein tagging in cells with split fluorescent proteinAdvances and perspectives in the application of CRISPR/Cas9 in insectsUsing CRISPR/Cas to study gene function and model disease in vivoEditing the Neuronal Genome: a CRISPR View of Chromatin Regulation in Neuronal Development, Function, and PlasticityCRISPR guide RNA design for research applicationsEpigenetic Editing: On the Verge of Reprogramming Gene Expression at WillEGRINs (Environmental Gene Regulatory Influence Networks) in Rice That Function in the Response to Water Deficit, High Temperature, and Agricultural EnvironmentsLigand-binding domains of nuclear receptors facilitate tight control of split CRISPR activityCpf1 nucleases demonstrate robust activity to induce DNA modification by exploiting homology directed repair pathways in mammalian cells.An inducible CRISPR-ON system for controllable gene activation in human pluripotent stem cells.Complex transcriptional modulation with orthogonal and inducible dCas9 regulators.CRISPR-Cas Genome Surgery in Ophthalmology.Genetic and epigenetic control of gene expression by CRISPR-Cas systems.Aptazyme-embedded guide RNAs enable ligand-responsive genome editing and transcriptional activation.Identification and characterization of a FOXA2-regulated transcriptional enhancer at a type 2 diabetes intronic locus that controls GCKR expression in liver cells.Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers.Conversion of embryonic stem cells into extraembryonic lineages by CRISPR-mediated activators.Effective knockdown of Drosophila long non-coding RNAs by CRISPR interference.CRISPR/Cas9 in allergic and immunologic diseases.Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR.Multiplexable, locus-specific targeting of long RNAs with CRISPR-Display.Genome-scale CRISPR-Cas9 knockout and transcriptional activation screeningGenome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activatorsTargeted genome regulation via synthetic programmable transcriptional regulators.Animal Models Are Valid to Uncover Disease Mechanisms.Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems.Practical Considerations for Using Pooled Lentiviral CRISPR Libraries.In Vivo Transcriptional Activation Using CRISPR/Cas9 in Drosophila.Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation.Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells.Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and DifferentiationReprogramming cell fate with a genome-scale library of artificial transcription factors.CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs
P2860
Q26744073-48F724B0-307A-4699-A101-C173B7190340Q26753182-23EBDE21-DB07-4BEF-8ACE-6E6DEA964C83Q26775746-51D9BCEE-4372-45CA-A248-0DB74D26C034Q26781399-C0E96315-85BF-4976-9D79-0FF24609A944Q26782747-19F9753F-4C49-41A9-A7A4-C61F8F73E10CQ26782876-DD683F6D-36C0-4F9B-848A-1911F09CFB26Q26787037-F2D1A325-1854-4306-9616-27BBD5FDFE3BQ27323123-9F6F2E31-EDC3-4847-BC62-9281CD8A2B8FQ27468938-0B641CD5-529B-49FF-A4BA-09B4DCB22D60Q28072587-5D507A9D-4A84-4716-8553-E922E0B2ACAEQ28075883-48409E3C-6EB6-44C0-A2E0-22994B208DD9Q28075898-9B49C8AA-BEB2-4E8A-90C2-91350CB0128AQ28080188-60034AB2-02D7-421B-91CC-A4657BAFA0D6Q28590260-34944ECF-D302-4F93-A322-1EEDAA0102B7Q28831343-6C194D2C-2180-4EB6-A85E-C2CAF9277E8CQ30374204-CD6F5F54-A22E-42E0-983D-30CE0B3A27CDQ30847500-06DAC6C2-7DE9-4E40-BB49-F8A504C6A535Q33704483-BADB9DA6-6810-42C8-BF23-8A304694BC2EQ33745403-47D214EF-3656-4EB2-9D4C-9BF2A5E340B5Q33777855-4128A23B-D009-4310-846B-7529690461FDQ33861368-139F300C-1C45-4BDB-9453-E5034DA41C0FQ33882617-3EF41098-520D-41DF-AEE4-D57008C5787BQ34043681-DEF48A79-B356-4F1B-9407-B19728434BB5Q34045868-F09282E0-C80F-4F98-9070-386A809FB4DDQ34046112-7B1BAAA3-E009-4ED5-9216-C79A90972E2BQ34047460-544F6FE9-80E8-473E-8909-A0909F033258Q34477489-05B8CB82-CE4F-423C-9DA4-CBDF0AF6C534Q34478710-D0D74FE9-4C14-47F4-AED0-400AE95DA26CQ34553929-7DC53199-4219-4647-B898-27CB7AFB2CB7Q35876055-68739A22-B5EC-4537-B837-F6C43FA90D13Q35993731-C3903EA2-B892-4C37-B0DC-5BD75CA52F65Q36030004-B24A03C9-94B9-4BD6-9D26-00DAAFB5209AQ36060923-B221BEB1-CE96-402B-96C0-E4E24BBDBF0DQ36065701-E19B9F0C-F05D-488A-9DEB-B90268ED84C9Q36132221-24654028-BB81-41DA-94F5-E05250A2C3C0Q36142402-D5B120D3-14C8-4B26-8808-63712029FC0CQ36178493-7818CA18-77D2-40D3-A3EC-DB8EDDCF3E6CQ36201570-AFBB55EB-1F41-4427-9498-E22E89A93538Q36215800-00395B26-5BA6-4AC7-B5F1-7F9A4E6D9566Q36250079-84A5FB4B-AB37-435C-A7F8-DF1AE4209905
P2860
Highly efficient Cas9-mediated transcriptional programming
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Highly efficient Cas9-mediated transcriptional programming
@ast
Highly efficient Cas9-mediated transcriptional programming
@en
type
label
Highly efficient Cas9-mediated transcriptional programming
@ast
Highly efficient Cas9-mediated transcriptional programming
@en
prefLabel
Highly efficient Cas9-mediated transcriptional programming
@ast
Highly efficient Cas9-mediated transcriptional programming
@en
P2093
P2860
P50
P356
P1433
P1476
Highly efficient Cas9-mediated transcriptional programming
@en
P2093
Alejandro Chavez
Christopher D Guzman
Daniel J Wiegand
Dmitry Ter-Ovanesyan
Eswar P R Iyer
James J Collins
Jonathan L Braff
Jonathan Scheiman
Marcelle Tuttle
P2860
P2888
P304
P356
10.1038/NMETH.3312
P577
2015-03-02T00:00:00Z